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ABSTRACT  
BACKGROUND: Histological grade is an independent prognostic variable in breast cancer 
(BC). Previous concordance studies of BC grade have reported moderate levels of agreement; 
a typical finding in morphological assessment of biological variables. This study aims at 
investigating the impact of discordance on the prognostic value of grade and identifying the 
best reporting approach in borderline cases. METHODS: A large (n=1675) well-characterised 
annotated cohort of BC originally graded in routine practice using glass slides was re-graded 
twice, by an expert breast pathologist using virtual microscopy with a three months washout 
period. Outcome was assessed using breast cancer specific and distant metastasis free 
survival (median follow-up =135 months). RESULTS: 58% of the cases showed absolute 
agreement in the three separate grading sessions whereas grade 1/2 and grade 2/3 
discordance were observed in 21% and 21% respectively. Absolute intra-observer agreement 
using virtual microscopy was observed in 77% of the cases whereas 13% and 10% showed 
grade 1/2 and grade 2/3 discordance respectively. Despite the concordance, outcome analysis 
revealed significant associations between tumour grade and patients’ outcome in the three 
grading sessions. Grade 1/2 and grade 2/3 discordant cases showed intermediate survival 
between grade 1 and grade 2 tumours and grade 2 and grade 3 tumours, respectively. Grade 
1/2 discordant cases showed a worse outcome when compared with grade 1 tumours (p=0.008) 
but no statistical difference was identified when compared with grade 2 tumours.  Similarly, 
grade 2/3 discordant cases showed a significant difference from grade 2 tumours (p<0.001) but 
no statistical difference was identified when compared with grade 3 tumours.  CONCLUSIONS: 
BC grade discordance is likely a reflection of biologically, and hence morphologically, borderline 
tumours. Cases with borderline features for grade are more likely to behave similar to the higher 
grade category.  Repeating histological grade of borderline cases or double reporting may 
improve correlation with outcome. 
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INTRODUCTION 
Histological grade of breast cancer (BC) is one of the strongest prognostic factors in early stage 
disease 1-3. Histological grade, using the Nottingham grading system comprises one of the main 
components of several management decision tools 4-8  and it has recently been included in the 
American Joint Committee on Cancer (AJCC) TNM staging system as a stage modifier 9.  A 
concern in regard to BC grading is the subjective nature of the technique with subsequent 
variation among pathologists in the assignment of all tumours into the same grades 10. A 
supposed advantage of modern era techniques, such as molecular biomarkers, is the high 
objectivity with a corresponding increase in reproducibility. However, in reality this perceived 
potential has yet to be realised as concordance of modern era molecular assays has not shown 
any improved agreement compared to human eye histological grading 11, 12. 
A distinct advantage of grading in addition to the low cost and short assessment time, is the 
relative ease in obtaining multiple opinions. From multiple opinions, discordance in grade 
assignments will most certainly arise. The most likely reflex for the resultant discordance is to 
be considered as a disadvantage. This is only true if discordance discovery offers no useful 
information or just reflects poor performance of the reader.  However, if a particular case is 
susceptible to discordance in grade assignment resulting from borderline morphological 
features it may reflect the biology of the tumour and its eventual behaviour.  
Increasing emphasis is being placed upon obtaining second or multiple opinions and with 
increasing use of digital pathology 13-17,  the number of second opinions is likely to further 
increase. Yet, it is not well understood how discordant grade assignments might impact risk 
assignment.  Knowledge of this might guide the methodology of how to integrate multiple 
opinions into quality assurance programmes, education, interpretation of research results, and 
into improved patient care.  
In a previous study we assessed the level of inter-observer and intra-observed concordance of 
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BC grading based on virtual microscopy (VM) as compared to the original glass-slides based 
grading 18 and this showed high concordance levels and demonstrated the reliability of VM in 
BC grading.  In this study, the impact of grade assignment discordance on patients’ outcome is 
investigated along with outlining practical guidelines on how to handle discordance. 
  
PATIENTS AND METHODS 
This study has been performed on a large series (n=1675) of early stage invasive primary BC 
patients presented to Nottingham City Hospital from 1999-2006. This is a well-characterised 
cohort of breast cancer (BC) with long-term clinical follow-up (median =135 months) and 
detailed clinicopathological profiles. Data included primary tumour histologic grade and grade 
components, tumour size and histotype, lymph node stage, lymphovascular invasion, 
Nottingham Prognostic Index (NPI) and oestrogen receptor (ER) status. Patients’ outcome 
information was collected and prospectively maintained. The latter include BC-specific survival 
(BCSS), defined as time (in months) from the date the primary surgical treatment to the time of 
death from BC, and distant metastasis free survival (DMFS) was defined as the time (in months) 
from primary surgery until the first event of distant metastasis. Patient and tumour 
demographics are summarised in Table 1. 
This tumour cohort was originally graded using the Nottingham grading system during routine 
pathology reporting using light microscopy (LM) and utilising all available tumour slides for each 
case (average four slides per case) 2. For the purpose of this study, data for the final grade as 
well as the individual grade components (tubule formation, nuclear pleomorphism and mitotic 
count scores) was retrieved from the patients’ records.  In addition, 1-3 tumour blocks per case 
were retrieved and freshly prepared H&E slides were reviewed. A representative slide per case 
was selected by a specialised breast pathologist (EA Rakha). The slides were selected based 
on the presence of adequate invasive tumour sufficient for VM grading regardless of the grade 
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of tumour tissue in the selected slide. Slides with artefacts, which would potentially interfere 
with image quality or grading, were excluded. Selected slides were scanned into high-resolution 
(0.19 μm/pixel) digital images at 20x magnification using 3D Histech Panoramic 250 Flash II 
scanner (3DHISTECH Ltd., Budapest, Hungary). Whole slide digital images (WSI) were 
generated, stored and viewed using the 3DHistech Pannoramic Viewer (3DHISTECH Ltd., 
Budapest, Hungary; http://www.3dhistech.com/downloads) on a high-resolution screen. For 
virtual microscopy (VM) grading, digital images were initially examined at low magnification 
where tubule formation was assessed. Also, low to intermediate magnification was performed 
for the identification of potential “hotspots” for mitotic counting. For mitotic counting, the 
distance measure tool of the software was used. This was important for determining the number 
of mitotic figures in a given area.  
To allow for intra-observer agreement assessment of BC grading using WSI, the whole cohort 
was graded again using the same criteria by the same observer (L Dalton who is an 
experienced breast pathologist with special interest in BC grading and digital microscopy). The 
second grading session was performed after a 3-month washout time without further training. 
In both WSI grading sessions (V1 and V2), grade components were assigned blinded to the 
original LM grade as well as other clinicopathological parameters.  
This study was approved by Nottingham Research Ethics Committee 2 under the title of 
“Development of a molecular genetic classification of breast cancer”. 
Survival analysis 
Survival analysis was performed using SPSS 23 (SPSS 23 for Windows, Chicago, IL, USA) 
using log rank test and Kaplan Meier plots. Much reliance was placed on simple inspection of 
survival curves 19. Survival analysis included separate determinations of BCSS and DMFS. The 
baseline grade assignment was the originally performed Nottingham grade by LM. From this 
baseline, two additional reviews generated by VM grading resulted in discordant assessments. 
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Survival curves were constructed which tracked the survival associated with 
concordance/discordance. Statistical significance in survival stratification was calculated by the 
log-rank method and univariate cox regression analysis. A p-value of less than 0.05 (two tailed) 
was considered significant.   
 
RESULTS 
In this study, two VM grading sessions were performed by an expert breast pathologist for a 
large (n=1675) clinically annotated early-stage primary invasive BC with a three-months 
washout period. 58% of the cases showed absolute agreement in all three grading (original LM 
grade and 2 VM grade) sessions (13%, 21% and 24% for grades 1, 2 and 3, respectively) 
whereas grade 1/2 and grade 2/3 discordance were observed in 21% and 21%, respectively 
(Table 2c).  High/low discordance was uncommon and occurred in only 26 cases (1.6%). The 
intra-observer agreement between the two VM sessions was 77%, whereas 13% and 10% 
showed grade 1/2 and grade 2/3 discordance, respectively (Table 2a). Only six cases (0.3%) 
had high/low discordance as assigned by one observer using VM.  Figures 1-3 illustrate 
examples of concordant and discordant grades and example of difficulty in the interpretation of 
mitotic figures at VM. 
Based on the original assessment, grade 2 tumours totalled 683 (41%) of the whole cohort. 
After VM1, the number of cases remained as grade 2 (i.e. in the intermediate category) was 
420 (25%) cases; VM1 has resulted in shifting of some grade 2 tumours into grade 1 (n=215) 
or 3 (n-48) tumours. Table 2 shows that VM tends to down grade tumours (p=1.0x10-13) with 
more cases assigned to lower-grade than the higher-grade categories. We assumed that the 
experience with digital microscopy is the reasons in the first session. However, the same 
observation was identified in the second session, which may reflect the relatively reduced ability 
to identify mitotic counts on the screen. To avoid the confounding effect of the platform on the 
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concordance, we analysed the impact on outcome using the two VM sessions and by one 
observer as well as the original LM grade assigned by different observer. 
Figure 4 shows the survival curve for the originally assigned grade, and for the first, and most 
naive, of the two VM sessions. The 342 discordant grade 1/2 tumours in the 3 grading sessions 
(Table 2c) showed a relatively favourable outcome compared to grade 2 tumours over the short-
term follow-up. However, long-term outcome analysis revealed survival figures concordant with 
grade 2 tumours (Table 3).  At the opposite end of the spectrum, concordant high grade tumours 
were associated with the worst patient outcome (Table 3). The 276 discordant grade 2/3 
tumours showed relatively better outcome compared to concordant grade 3 BC during the early 
follow-up times however; this meagre improvement disappeared after longer-term follow-up and 
the final outcome of these grade 2/3 discordant cases was similar to grade 3 concordant 
tumours.  
To test for how the alteration of the original grade might be impacted by 
discordance/concordance of the additional reviews using WSI, concordance of VM1 and VM2 
was explored.  Comparison of the two VM grading sessions showed a smaller number of 
discordant assessments reflecting high level of intra-observer concordance. The outcome of 
discordance as related to the 2 VM grade assignment sessions is outlined in figure 5. Again, 
the discordant assignments corresponded to interval levels of patients’ survival.  In addition, it 
also demonstrated the existence of “solid” or repeatable intermediate grade tumours. Survival 
curves in figure 6 display these results. A repeatable intermediate grade assignment is more 
aligned with intermediate survival. Meanwhile grade 2/3 discordant cases in the 2 VM sessions 
were more aligned with the original high-grade assignment. Figure 7 allows visualisation at the 
grade 1/2 end of the spectrum.  
When the cohort was stratified into oestrogen receptor positive (ER+) and negative (ER-) 
subgroups it was in the ER+ subset where interval levels of survival corresponded to discordant 
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grade assignment. In the ER- negative group no statistical significance was found in survival of 
grade 2, grade 2/3 or grade 3 cases. Table 4 shows the distribution of ER status among the 
five concordance/discordance levels. Also, the distribution of discordance/concordance levels 
seen in patients of younger age is listed. Less than 46 years was chosen given the high 
probability that patients under this age are pre-menopausal20. 
 
DISCUSSION 
In the seminal paper on assessment of histological grade 21 each tumour was graded 
independently by two observers. In those tumours having had discordant grade assignment, 
the observers resolved the matter by joint review at a dual-headed microscope. Therefore, at 
the outset grading was accomplished by the review of two pathologists. Strictly speaking, the 
procedure used in the original validation study, should be the procedure used going forward. 
Of course, since then the practice of single pathologist review is common, and many datasets 
have shown significance of grade based on a single revision review. With the increasing 
expectations for outside-institutional second review, and with the advent of digital microscopy, 
discordance will be encountered, or “discovered” more frequently among different pathologists. 
Therefore, the current investigation is partly a matter of necessity. Especially since those 
rendering second opinions may not have any incentive to arrive at a collegial joint decision. 
Subsequently, questions might arise as to: who might be correct or who might be wrong.  There 
may be no right or wrong if discordant assessments belong into separate and potentially 
informative categories. The ultimate aim was to test whether discordant assessments can be 
allocated into separate and potentially informative categories. In other words, to explore the 
hypothesis that grade discordance is a biological rather than a pure technical phenomenon.  
Based on the findings herein, all opinions may be correct bearing in mind the nature of a cancer 
itself when it expresses borderline attributes, be they phenotypic, genotypic, or proteomic, 
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therefore raising the susceptibility to discordance in risk assignment. In other terms, 
discordance may not be resulting from observers’ faults, whether it is a man or a machine, but 
an inherent cancer trait. If tumours with discordant grade assignments are linked to a robust 
patient outcome data, impact of discordance could be interrogated whether it affects patients’ 
risk stratification and hence management. The more advantage of our approach is having 
discordance discovery become procedural or, at least, it is worthwhile to expand our knowledge 
as to the meaning of discordance.  
An advantage of modern genomic and molecular techniques is their potential for higher 
objectivity with a corresponding increase in reproducibility as compared to the known subjective 
human eye histological grading. However, concordance of modern assays is showing no or 
marginal agreement 11, 12, 22-24. Because of technical ease, low cost, and in that grading does 
not consume additional tissue, grading could be considered to hold a unique advantage to 
molecular techniques. Furthermore, with grading, discordance/concordance discovery is 
feasible. It is dubious that discordance in risk assignments, both in morphological parameters 
or molecular biomarkers, will be completely eliminated. To our knowledge this is the largest 
study of its kind with the approach followed in this report serving as an illustrative start point.  
The findings here, and prior work 25 contravene conventional wisdom. As for two separate 
opinions, concordance/discordance discovery constructed a risk scale with five categories. The 
originally assigned grade was, of course, a three-category scheme. A five-category risk scale 
affords more flexibility in deciding patient treatment strategies. For instance, if those patients 
with ER positive tumours show concordance of high grade assignment, it may be deemed 
reasonable to assume that the patient is located at the definite higher risk end of the spectrum 
related to tumour grade. In other terms, the agreement between two assignments of high grade 
can increase pathologists’ confidence that the tumour being is a real risk to patient survival. 
The opposite recommendation is applicable to concordant low-grade ER positive tumours, 
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which in this case are better treated with hormone manipulation without chemotherapy. 
Although the five-tier system is more reflective of tumour biology and provides detailed 
representation of BC heterogeneity and more accurate patients’ risk stratification, using five 
categories in routine practice could also be associated with its own disadvantages. There is a 
tendency to apply prognostic variables in a dichotomised fashion to allow further management 
of patients in terms of systemic therapy. Regardless of a three-tier or five-tier system, 
oncologists tend to translate data into a binary variable to decide further management options 
making the three-tier system more pragmatic. Also, the five-tier system requires that all BC be 
double graded which has time and cost implications. Importantly, Nottingham grading as a 
ternary scheme has been so well validated it is not advisable to adjust to a five-tier scheme 
without further study. Favoured is to simply note in a report that grading in a given case has 
been based on consensus review. Findings of the current study would suggest, that until proven 
otherwise, to assign adjacent level discordance into the higher grade. High versus low grade 
discordance should certainly be subjected to thorough scrutiny. 
The results of this study demonstrate the association between grade discordance and outcome, 
which we interpreted as a reflection of tumour biology and hence the differences in the outcome. 
Concordant grade 1 cases, the lowest risk group in our five-category risk scale, appears to 
represent the very well differentiated cancers at one end of the differentiation continuum, while 
concordant grade 3 cases were the least differentiated at the other end. This study highlights 
the importance of inter-tumour heterogeneity of BC and that some tumours show borderline 
molecular features 26, and hence borderline morphological characteristics, making tumour 
assignment into a specific grade category subjective and challenging. These tumours comprise 
the majority of grade discordant cases as demonstrated by the association with distinct 
outcome in-between the two concordant grade cases. Intra-tumour heterogeneity may also 
contribute to grade discordance in research studies, including this study; if different slides are 
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used in grading by different observers. This may explain discordance in few cases in this study 
in which the original grade was assigned based on examination of 4 tumour slides whereas the 
virtual grade assignment was based on one slide that represents part of the tumour. 
In view of outcome analysis in this study linking tumour biology to grading assignment, the 
impact on pathology practice is twofold. Firstly, BC showing grade discordance between 
reporting pathologists are likely to eventually behave in a way similar to the higher-grade 
category and are likely to have high risk than the assigned lower grade. Thus, if more opinion 
is sought, the higher the grade assignment, the higher the risk the tumour may have. Secondly, 
some tumours will be assigned to grade 2 category regardless of the number of reviews 
indicating that grade 2 BC is genuine intermediate grade along the risk scale and not just a 
basket for lack of assignment of cases. Using molecular assays to assign BC into two grades 
may not be an optimal approach for risk stratification of individual tumours especially 
intermediate risk cases 26, 27. Using other prognostic variables in these cases to determine BC 
outcome and behaviour is warranted rather than assigning these intermediate grade 
prognostically borderline tumours into one of the extreme end categories.  
One caveat pertains to grade one versus two discordance. As seen by survival curve 
inspection, in the short term (60 months) low/intermediate track with low grade. It is over a 
longer term where grade 1 versus grade 2 discordance inclines toward intermediate. The short-
term behaviour may influence the decision to avoid treatments which are aimed at short term 
response, especially if a treatment cut-point has been set for high sensitivity. 
Until there is further validation no formal rules are proposed based on findings of this study. 
Instead, we would offer two recommendations. Firstly, to maintain the original procedure 
described by Elston and Ellis, and if discordance is discovered, then resolve discordance by 
collegial peer review. Should discordance occur beyond a peer setting, it cannot be assumed 
that the original opinion deserves the label of mistake or error. Instead, the difference may best 
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be attributed to the inherent nature of the tumour itself. Secondly and in view of the time and 
cost limitations, it is suggested that it is useful to review tumours with borderline features by the 
same pathologist (after a time interval) or by a different pathologist.  Based on practice 
experience, pathologists are usually aware if they are having some difficulty in deciding 
between low and intermediate grade (i.e., score five versus score six tumour) or intermediate 
and high grade (score seven versus eight) tumours. These are the cases that could 
potentionally be subject to a second opinion. Audits of grade in routine practice can also help 
in identifying the proportions and features of tumours reported by different pathologists that 
should be submitted for a second opinion. The findings here can help guide how to resolve the 
discordance.  
An additional recommendation pertains to research studies. If dual (or more) pathologist review 
is performed, then level of pathologist reproducibility must be assessed at level of consensus 
before grading can be criticised for lack of reproducibility. Decades ago, it was shown that 
consensus opinion among groups had higher reproducibility than individual opinions, and 
consensus opinion corrected for outliers 28.   
In this study, whilst a single histopathologist provided the two additional grade assessments 
and the observations might be strengthened by assessments of additional histopathologists, 
the large number of cases in this study and the ability to correlate intra-observer concordance 
with outcome reinforce the value of the current study. Also grade assignments had been 
rendered on different microscopy platforms; namely LM and VM, New sentence? in routine 
practice the additional opinions are increasingly obtained using digital microscopy of WSI.  
Moreover, it may seem that attributing interobserver (LM vs VM grading) and intra-observer 
(VM1 and VM2 grading) to differences to intrinsic biology of the tumour may inadvertently 
reduce the importance of achieving grading consistency by different observers, However, we 
would like to emphasise that this phenomenon is a typical feature of biological processes 
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particularly those assessed based on morphological characteristics, such as tumour 
differentiation by BC histological grading. Importantly discordance was limited to certain 
tumours whereas the majority of the tumours were consistently assigned to specific grade 
category. These discordant tumours also showed distinct outcome and their identification can 
help refining risk stratification of patients. It is also important to highlight that the results of this 
study refer to discordance of grade between expert pathologists, which is mainly related to 
intrinsic tumour features and not related to a difference in the application of grade methodology 
or inability of individual pathologists to consistently assign the “correct” grade.   
In this study, we also noticed that mitotic figure recognition is not optimal on VM slides. As VM 
is a relatively emerging procedure, more practice and comparing the morphology of mitotic 
figures in LM and VM will help to establish the criteria and experience to identify mitotic figures 
with reproducible accuracy. A study to improve our ability to identify mitotic figures and 
differentiate them from apoptotic bodies using high-resolution and high-definition digital images, 
using Z-stacking image technology and immunohistochemistry for staining of mitotic cells is 
also proposed. 
From a future perspective, the VM grade represents a realistic platform as the use of digital 
microscopy is currently expanding making the second review accomplishable.  Further 
investigation of the findings of the current study could be achieved by integration of VM 
grading/second opinion into QA and/or educational programmes. The involvement of practising 
pathologists would test, in real practice, the concordance levels between observers/graders as 
grading of this cohort has been performed by expert breast pathologists. Moreover, the 
integration of this VM grading into educational programmes could help accomplish training 
tasks and to audit trainees’ performance compared to experts.  
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Tables 
Table 1: Characteristics of the cohort of invasive breast cancer included in this study  
Parameters Number of cases (%) 
Age 
  >50 
  ≤50 
  Missing 
 
1098 (65.6)  
549 (32.8) 
28 (1.7) 
Tumour size  
  > 2.0cm 
  ≤2.0cm 
  Missing 
 
588 (35.1)  
1058 (63.2) 
29 (1.7) 
Lympho-vascular Invasion 
  Negative 
  Positive 
  Missing 
 
1197 (71.5)  
450 (26.9) 
28 (1.7) 
Lymph node status  
  Negative  
  Positive  
  Missing 
 
1132 (67.6) 
515 (30.7) 
28 (1.7) 
Lymph Node Stage 
  1 
  2 
  3 
Missing 
 
1027 (62.4)  
457 (27.3)  
162 (9.7) 
29 (1.7) 
Nottingham Prognostic Index  
  Good  
  Moderate  
  Poor 
  Missing 
 
568 (33.9)  
820 (49)  
256 (15.3) 
31 (1.9) 
Histologic types 
  Ductal NST  
  Lobular  
  Tubular/Invasive Cribriform 
  Pure Mucinous  
  Invasive Micropapillary  
  Other types including Medullary-like  
 
1258 (75.1)  
102 (6.1)  
60 (3.6) 
22 (1.3)  
13 (0.8)  
220 (13.1) 
Distant metastasis  
  Yes  
  No  
  Missing 
 
357 (21.3)  
1288 (76.9)  
30 (1.6) 
Outcome Status at end of follow-up  
  Alive  
  Died from Breast cancer  
  Died from other causes  
  Missing 
 
1190 (71)  
297 (17.7)  
156 (9.3)  
32 (1.9) 
 17
Table 2: Cross comparison of the two virtual microscopy grading sessions (VM1 and VM2) (Table 2a) 
and between the light microscopy (LM) grading and both virtual grading sessions (Table 2b) and 
between the 3 grading sessions (Table 2c) 
 
Table 2a 
Grade VM1 
Grade VM2 
Total percentage 
Grade 1 Grade 2 Grade 3 
Grade 1 363 107 2 28.2 
Grade 2 101 504 67 40.1 
Grade 3 4 106 421 31.7 
Total Percentage 27.9 42.8 29.3 100 
Percent exact agreement: 77%, Percent adjacent level: 22.7%, Percent high/low: 0.3% 
 
 
Table 2b 
Grade (VM1 and 2) 
Grade (Light Microscopy) 
Total percentage 
Grade 1 Grade 2 Grade 3 
  Grade 1   VM1 
                   VM2 
232 
233 
215 
210 
25 
25 
28.2 
27.9 
  Grade 2   VM1 
                   VM2 
39 
37 
420 
440 
213 
240 
40.1 
42.8 
  Grade 3   VM1 
                   VM2 
1 
2 
48 
33 
482 
455 
37.1 
29.3 
Total Percentage 16.2 40.8 43.0 100 
Percent exact agreement: 68%, Percent adjacent level: 30.5%, Percent high/low: 1.5% 
 
 
 
Table 2c 
Grade (Light 
Microscope) 
Grade VM1 
Grade VM2 Total 
percentage Grade 1 Grade 2 Grade 3 
Grade 1 Grade 1    
Grade 2 
Grade 3 
212 
21 
0 
19 
17 
1 
1 
1 
0 
28.2 
 
Grade 2 Grade 1    
Grade 2 
Grade 3 
138 
71 
1 
76 
335 
29 
1 
14 
18 
40.1 
 
Grade 3 Grade 1    
Grade 2 
Grade 3 
13 
9 
3 
12 
152 
76 
0 
52 
403 
37.1 
 
Total Percentage 27.9 42.8 29.3 100 
Percent exact agreement: 58%, Percent adjacent level: 41.2%, Percent high/low: 0.8% 
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Table 3: Probability of patient survival (Life table analysis) corresponding to concordance and 
discordance of originally assigned grade with the two VM additional reviews (VM1 and VM2).  
 
Grade 
Interval Start 
Time (months) 
Number Entering 
Interval 
Number Exposed 
to Risk 
Number of 
Terminal Events 
Proportion Surviving Cumulative Proportion 
Surviving at End of 
Interval 
Grade 1 0 205 205 0 1.00 1.00 
 30 202 200 2 0.99 0.99 
 60 197 189 3 0.98 0.97 
 90 178 166 2 0.99 0.96 
 120 153 129 1 0.99 0.96 
 150 104 68 3 0.96 0.91 
Grade 1/2 0 334 332 1 1.00 1.00 
 30 329 322 5 0.98 0.98 
 60 309 296 3 0.99 0.97 
 90 279 261 9 0.97 0.94 
 120 233 188 8 0.96 0.90 
 150 134 95 5 0.95 0.85 
Grade 2 0 329 325 5 0.98 0.98 
 30 316 310 8 0.97 0.96 
 60 296 280 10 0.96 0.93 
 90 255 239 5 0.98 0.91 
 120 218 175 8 0.95 0.86 
 150 125 91 4 0.96 0.83 
Grade 2/3 0 335 332 13 0.96 0.96 
 30 315 311 24 0.92 0.89 
 60 283 270 18 0.93 0.83 
 90 239 226 22 0.90 0.75 
 120 191 150 9 0.94 0.70 
 150 99 73 5 0.93 0.65 
Grade 3 0 399 395 34 0.91 0.91 
 30 357 353 44 0.88 0.80 
 60 304 293 21 0.93 0.74 
 90 260 240 7 0.97 0.72 
 120 213 171 4 0.98 0.70 
 150 125 93 0 1.00 0.70 
 
 
 
 
Table 4: Distribution of concordance/discordance levels corresponding to oestrogen receptor (ER) 
status, and cancers occurring in younger patients having a high chance for premenopausal status (age < 
46). 
   
 ER positive 
No (%) 
ER negative 
No (%) 
Age <46 years 
No (%) 
Concordant low grade 224 (16.6) 2 (0.7) 8 (2.5) 
Discordant low/intermediate 245 (18.2) 2 (0.7) 25 (7.8) 
Concordant intermediate 395 (29.3) 18 (5.9) 58 (18.0) 
Discordant intermediate/high 212 (15.8) 45 (14.9) 65 (20.2) 
Concordant high  244 (18.2) 235 (77.6) 158 (49.1) 
High/low discordance 24 (1.7) 1 (0.3) 8 (2.5) 
Number of Patients 1344 303 322 
 
The above represents a summary with regard to the originally assigned grade and the first of the additional VM reviews; 
VM1 and VM2.  
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Figure legends 
 
 
 
 
Figure 1: Photomicrographs demonstrating grade concordance between VM1 and VM2; A) A case of concordant 
Grade 1 tumour, B) A case of concordant Grade 2 tumour, C) An example of concordant Grade 3 tumour.  
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Figure 2: Photomicrographs illustrating discordance in grade (discordance between VM1 and VM2. A) A case of 
Grade 1/2 discordance; and B) a case of Grade 2/3 discordance) that represent borderline morphological features 
(tubule formation in A and pleomorphism in B).  
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Figure 3: A case illustrating difficulties in differentiating mitotic figures from apoptotic bodies on virtual 
microscope grading. It is scored 3 for mitotic count using glass slides and scored 1 on the digital image (High 
power view; 200x).   
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Figure 4: Kaplan Meier survival curves comparing Nottingham grade originally assigned (A) with the 
first additional review grade (based on virtual microscopy) (B). 
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Figure 5: Association between histologic grade concordance and outcome (A- breast cancer specific 
survival [BCSS] and B- distant metastasis free interval [DMFI]; both p<0.00001). Red curves represent 
tumours with grade concordance (grade 1: upper curve, grade 2: middle curve and grade 3: lower 
curve) in both VM sessions. Black curve represents cases with grade 1 and 2 discordance whereas grey 
curve represents cases with grade 2 and 3 discordance.  
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Figure 6: Association between grade 2/3 concordance and BCSS (p<0.00001). Red curves represent 
tumour with grade concordance in all 3 grading sessions (grade 2: upper curve and grade 3: lower 
curve). Grey curve represents cases with grade discordance; original grade 3 and then grade 2 in the 
two sessions whereas purple curve represents cases with original grade 3 and one grade 3 and one 
grade 2 in the two sessions.  
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Figure 7: Association between grade 1/2 concordance and BCSS (p=0.001). Red curves represent 
tumour with grade concordance (grade 1: upper red curve and grade 2: lower red curve) in all 3 grading 
sessions. Grey curve represents cases with grade discordance; original grade 1 and then one grade 1 
and one grade 2 in the two sessions, the blue curve represents cases with original grade 2 and the grade 
1 in both sessions whereas the purple curve represents cases originally graded as 2 and then as one 
grade 2 and one grade 1 in the two sessions.  
 
 
 
 
 
 
 
 
 
 
 
